We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cyclofluidic Announces its Automated Chemical Synthesis-To-Screen Process for Drug Discovery

News   Mar 16, 2011

 
Cyclofluidic Announces its Automated Chemical Synthesis-To-Screen Process for Drug Discovery
 
 
 

RELATED ARTICLES

Microbe Motility Enhanced by Microbiome Metabolites in Colon Chip

News

By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.

READ MORE

AI Utilized to Predict Cancer's Migration to the Brain

News

A new precision medicine approach developed at the University of Michigan aims to predict cancer’s likelihood of migrating to the brain, and to aid in the search for new treatments

READ MORE

3D Bioprinted Tubules Mimic Kidney Reabsorption

News

A 3D vascularized proximal tubule module enables the study of renal absorption, a key aspect of drug development and disease modeling.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE